Y Su1, J Rothers, D A Stern, M Halonen, A L Wright. 1. Arizona Respiratory Center, College of Public Health, Department of Pharmacology, University of Arizona, Tucson, AZ 85724, USA.
Abstract
BACKGROUND: Findings from studies of the relation between early antibiotic use and subsequent asthma have been inconsistent, which may be attributable to methodologic issues. OBJECTIVE: Our objective was to assess the impact of confounding by indication on the relation of early antibiotic use to childhood asthma through age 5 in a non-selected birth cohort (n=424). METHODS: Oral antibiotic use was assessed by frequent nurse interviews in the first 9 months of life. Physician-diagnosed active asthma and eczema were assessed by questionnaire at 1, 2, 3, and 5 years, and were considered as ever asthma or ever eczema if positive at any age. Allergen-specific IgE was assessed in plasma at 1, 2, 3, and 5 years. Confounding by indication was investigated by considering the relation of asthma to antibiotic use while controlling for the number of illness visits to a physician in early life. RESULTS: There was no statistically significant relation of early antibiotic use with physician-diagnosed eczema or allergen-specific IgE. A dose-response relation was evident for antibiotic use with ever asthma (odds ratio [OR]=1.5, P=0.047). Ever asthma also increased significantly with the number of illness visits to a physician (P<0.001). After adjustment for number of illness visits, antibiotic use showed no relation with asthma. CONCLUSIONS: The relation of asthma to antibiotics in this cohort appears to be an artefact of the strong relation of number of physician visits for illness with both antibiotic use and risk for asthma.
BACKGROUND: Findings from studies of the relation between early antibiotic use and subsequent asthma have been inconsistent, which may be attributable to methodologic issues. OBJECTIVE: Our objective was to assess the impact of confounding by indication on the relation of early antibiotic use to childhood asthma through age 5 in a non-selected birth cohort (n=424). METHODS: Oral antibiotic use was assessed by frequent nurse interviews in the first 9 months of life. Physician-diagnosed active asthma and eczema were assessed by questionnaire at 1, 2, 3, and 5 years, and were considered as ever asthma or ever eczema if positive at any age. Allergen-specific IgE was assessed in plasma at 1, 2, 3, and 5 years. Confounding by indication was investigated by considering the relation of asthma to antibiotic use while controlling for the number of illness visits to a physician in early life. RESULTS: There was no statistically significant relation of early antibiotic use with physician-diagnosed eczema or allergen-specific IgE. A dose-response relation was evident for antibiotic use with ever asthma (odds ratio [OR]=1.5, P=0.047). Ever asthma also increased significantly with the number of illness visits to a physician (P<0.001). After adjustment for number of illness visits, antibiotic use showed no relation with asthma. CONCLUSIONS: The relation of asthma to antibiotics in this cohort appears to be an artefact of the strong relation of number of physician visits for illness with both antibiotic use and risk for asthma.
Authors: Juan C Celedón; Augusto A Litonjua; Louise Ryan; Scott T Weiss; Diane R Gold Journal: Am J Respir Crit Care Med Date: 2002-07-01 Impact factor: 21.405
Authors: Fawziah Marra; Carlo A Marra; Kathryn Richardson; Larry D Lynd; Anita Kozyrskyj; David M Patrick; William R Bowie; J Mark Fitzgerald Journal: Pediatrics Date: 2009-03 Impact factor: 7.124
Authors: Emma E Thompson; Rachel A Myers; Gaixin Du; Tessa M Aydelotte; Christopher J Tisler; Debra A Stern; Michael D Evans; Penelope E Graves; Daniel J Jackson; Fernando D Martinez; James E Gern; Anne L Wright; Robert F Lemanske; Carole Ober Journal: J Allergy Clin Immunol Date: 2013-02-21 Impact factor: 10.793
Authors: Brittney M Donovan; Andrew Abreo; Tan Ding; Tebeb Gebretsadik; Kedir N Turi; Chang Yu; Juan Ding; William D Dupont; Cosby A Stone; Tina V Hartert; Pingsheng Wu Journal: Clin Infect Dis Date: 2020-04-10 Impact factor: 9.079
Authors: Janet Rothers; Marilyn Halonen; Debra A Stern; I Carla Lohman; Sara Mobley; Amber Spangenberg; Dayna Anderson; Anne L Wright Journal: J Allergy Clin Immunol Date: 2011-06-16 Impact factor: 10.793
Authors: Marilyn Halonen; I Carla Lohman; Debra A Stern; Whitney L Ellis; Janet Rothers; Anne L Wright Journal: Am J Respir Crit Care Med Date: 2013-07-01 Impact factor: 21.405